Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study hypothesis is that clearer visual presentation of guideline recommendations and educational outreach, or academic detailing, can improve guideline compliance. However, it will investigate other aspects of screening-related decision-making, such as provider and patient beliefs about screening, provider-patient communication and patient's willingness to forgo expected testing. The research question is whether educational interventions can decrease non-compliance with screening guidelines for 5 common cancers.
This study is a cluster randomized trial that compares the immediate post-encounter impressions of 12 physicians and 18 of their patients about the discussion of screening for breast, cervical, colorectal, lung and prostate cancer as well as their beliefs about screening efficacy and patient reports of the screening experience. The interventions are educational materials and academic detailing (educational outreach) for providers. The investigators are particularly interested in contrasting the patient and provider recollections, the differential impact on underuse and overuse compliance and whether patient behaviors are consistent with their stated screening plans.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard Support Outreach | Active Comparator | Providers receive standard written screening recommendations and do not receive academic detailing (educational outreach) |
|
| Standard materials and academic detailing | Experimental | Providers receive standard written screening recommendations and receive academic detailing (educational outreach) |
|
| Color-coded materials and no academic detailing | Experimental | Providers receive color-coded written screening recommendations and do not receive academic detailing (educational outreach) |
|
| Color-coded materials and academic detailing | Experimental | Providers receive color-coded written screening recommendations and receive academic detailing (educational outreach) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Color-coded materials | Other | A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Effect of educational intervention on providers' recommendations | Incidence of guidance compliance | Baseline |
| Effect of educational intervention on providers' recommendations | Incidence of guidance compliance | 3 months |
| Effect of educational intervention on providers' recommendations | Incidence of guidance compliance | 6 months |
| Effect of educational intervention on providers' recommendations | Incidence of guidance compliance | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Patients' belief in the value of screening | measured by survey to be determined | Baseline |
| Patients' belief in the value of screening | measured by survey to be determined |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| James A Talcott, MD SM | Mount Sinai Beth Israel | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mount Sinai Beth Israel | New York | New York | 10003 | United States | ||
| St. Luke's-Roosevelt |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| D002583 | Uterine Cervical Neoplasms |
| D011471 | Prostatic Neoplasms |
| D003110 | Colonic Neoplasms |
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Academic detailing | Other | Educational outreach to address the rationale and data supporting recommendations for and against screening |
|
| Standard support | Other | Screening recommendations presented in standard format |
|
| No academic detailing | Other | Physician receives study orientation for not the academic detailing curriculum |
|
| 3 months |
| Patients' belief in the value of screening | measured by survey to be determined | 6 months |
| Patients' belief in the value of screening | measured by survey to be determined | 12 months |
| Patient compliance | measured by self- report in surveys to be determined | Baseline |
| Patient compliance | measured by self- report in surveys to be determined | 3 months |
| Patient compliance | measured by self- report in surveys to be determined | 6 months |
| Patient compliance | measured by self- report in surveys to be determined | 12 months |
| New York |
| New York |
| 10019 |
| United States |
| D017437 |
| Skin and Connective Tissue Diseases |
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D005834 | Genital Neoplasms, Male |
| D005832 | Genital Diseases, Male |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |